| Serial Number | 79252897 |
| Word Mark | IMMODULON |
| Filing Date | Monday, September 24, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 31, 2019 |
| Registration Number | 5946864 |
| Registration Date | Tuesday, December 31, 2019 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 15, 2019 |
| Indication of Colors claimed | The color(s) dark blue, teal, and white is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of the stylized wording "IMMODULON", where "IMM" is in white and surrounded by a shaded teal circle and "ODULON" is in dark blue. All other instances of the color white in the mark represent background and/or transparent areas only and are not claimed as features of the mark. |
| Goods and Services | Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation |
| Goods and Services | Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 11, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 11, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 11, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Immodulon Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Immodulon Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Immodulon Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, May 8, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, April 16, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, April 16, 2020 | FINAL DISPOSITION PROCESSED |
| Tuesday, March 31, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, December 31, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 15, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 15, 2019 | PUBLISHED FOR OPPOSITION |
| Saturday, October 12, 2019 | NOTIFICATION PROCESSED BY IB |
| Wednesday, September 25, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 25, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 25, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, September 12, 2019 | ASSIGNED TO LIE |
| Wednesday, September 11, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 10, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 9, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 9, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, April 6, 2019 | REFUSAL PROCESSED BY IB |
| Thursday, March 21, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, March 21, 2019 | REFUSAL PROCESSED BY MPU |
| Friday, March 15, 2019 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 13, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, March 12, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, March 11, 2019 | ASSIGNED TO EXAMINER |
| Monday, March 11, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, March 8, 2019 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, February 28, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |